THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW.

9 June 2026

 capAI plc
(the "Company" and, together with its subsidiaries, the "Group" or "capAI")

Public Availability of Movie42 and Gamers42 Beta Applications, Expanded Author42 Capabilities and Live Product Webinar

capAI plc (LSE: CPAI, OTCQB: CPIQF), the applied artificial intelligence ("AI") venture platform, is pleased to announce the public availability of its Movie42 and Gamers42 beta applications, significant enhancements to Author42 and a live product webinar to be held on Friday, 12 June 2026 at 9:00 a.m. Pacific Time (PT) / 5:00 p.m. British Summer Time (BST).

Further to the Company's AGM Trading & Strategic Update announced on 21 April 2026 ("AGM Update"), this Announcement provides an update on the continued development and rollout of capMedia's content creation platform portfolio, including new functionality and public access to Movie42 and Gamers42 beta applications.

The Company will also host a live product webinar on Friday, 12 June 2026, to provide shareholders, subscribers and users across the Group's platform portfolio with an opportunity to see capMedia's latest AI-powered applications operating live, including demonstrations of AI-assisted authoring, AI-generated movie trailers and browser-based game creation from books and written content.

Interested participants may register at:

https://us02web.zoom.us/webinar/register/WN_cch3Kt_YSCWOQMSglb4NOw

Professor Ronjon Nag, Executive Chairman, commented:

"Over the past year we have focused on building a portfolio of AI-powered content creation platforms. With Author42 operational and Movie42 and Gamers42 now publicly available in beta, we are entering the next phase of development focused on user acquisition, commercial evaluation, and monetisation.

We believe these technologies have the potential to help creators extend a single intellectual property asset across written, visual and interactive formats while opening up new opportunities for audience engagement. We look forward to demonstrating these capabilities during our webinar on 12 June."

Live Product Webinar

The live product webinar, to be held at 9:00 a.m. Pacific Time (PT) / 5:00 p.m. British Summer Time (BST) on Friday, 12 June 2026, will include live demonstrations of capMedia's three platforms:

·      Author42 - AI-assisted nonfiction and fiction writing, validation and worldbuilding

·   Movie42 (Beta Application) - cinematic AI-generated trailers generated from books, stories, brands and concepts

·     Gamers42 (Beta Application) - browser-based 2D and 3D games generated from a few lines of text, chapters or complete books

The webinar will also include a live question-and-answer session.

Registration details will be distributed through capAI's communication channels and directly to registrants, and to subscribers and users across capMedia's platform portfolio.

A recording of the webinar will be made available to registrants following the event.

capMedia Platform Portfolio Update

Further to AGM Update, the Company is pleased to provide additional information regarding a number of AI-powered content creation platforms being developed and evaluated by capMedia.

While the platforms described below are complementary and may be used together by users, each operates as a standalone product with its own branding, website, functionality and potential commercial applications.

For clarity, certain products referred to in the AGM Update have since been renamed. The video-generation product previously referred to as Creator42 is now Movie42, and the game-generation product previously referred to as Game42, is now Gamers42.

Author42

Author42 is the Company's AI-assisted writing platform and is currently operational and available to users.

The platform supports nonfiction, memoir and fiction writing workflows, combining concept validation, planning, drafting and editing tools designed to assist authors throughout the writing process. Recent development has focused on expanding fiction-writing functionality and enhancing editing and workflow capabilities.

Movie42 (Beta Application)

Movie42, previously referred to as Creator42, is now publicly available in beta.

The platform enables users to transform books, stories, brands and concepts into AI-generated cinematic trailers and visual content. Content can be generated from existing manuscripts, plain-text concepts or public-domain literary works.

The Company is currently onboarding users and gathering feedback as part of its ongoing product refinement and commercial evaluation process.

Gamers42 (Beta Application)

Gamers42, previously referred to as Game42, is now publicly available in beta.

The platform enables users to transform a few lines of text, individual chapters or complete books into playable browser-based games without coding.

The platform supports multiple visual styles ranging from 2D experiences through to fully rendered 3D gameplay. Through natural-language interaction, users can rapidly create and refine games, significantly reducing the technical barriers traditionally associated with game development.

As with Movie42, Gamers42 is now available to users as part of an ongoing programme of onboarding, testing, product refinement and commercial evaluation.

capMedia Strategy

capMedia's strategy is to develop and evaluate AI-enabled products that support content creation, adaptation and audience engagement across multiple media formats.

The Company's board of directors ("Board") believes advances in generative AI are creating opportunities for individuals to create and extend intellectual property with significantly reduced cost and complexity. While each platform operates independently, users may choose to utilise multiple products together to develop written, visual and interactive content from a single underlying idea or creative work.

The Company believes this approach has the potential to increase user engagement and create additional commercial opportunities across its platform portfolio.

capMedical Update

Further to previous announcements, the Company continues to evaluate opportunities under its capMedical initiative, including longevity-focused programmes and other healthcare applications where artificial intelligence may accelerate innovation and value creation.

A number of projects remain under active review as the Company assesses their scientific, technical and commercial potential.

The Company expects any future capMedical initiatives to be evaluated using the same disciplined and capital-efficient framework applied across its broader portfolio.

Disciplined Venture Structure

The Company has to date operated a venture model securing rights to acquire or license technologies developed in collaboration with R42 through licence and option agreements.

This structure enables capAI to evaluate multiple opportunities in a capital-efficient manner while retaining exposure to potential upside through option-based access to successful projects.

However, shareholders should note that there can be no guarantee that the Company will ultimately exercise any option to acquire or license such projects. Decisions to proceed are made selectively based on technical progress, market potential and capital allocation considerations.

Outlook

The Board believes that the public availability of Movie42 and Gamers42 beta applications, together with the forthcoming live product webinar, represent important milestones in the Company's transition from platform development to user engagement, commercial evaluation and monetisation.

The combination of AI-assisted authoring, cinematic content generation and browser-based game creation provides creators with the opportunity to extend a single intellectual property asset across multiple media formats while potentially creating new audience and revenue opportunities.

The Company remains focused on disciplined execution, capital efficiency and the selective advancement of high-potential AI opportunities across creative industries and healthcare.

Further updates will be provided in due course.

Enquiries

Company:

capAI plc                      [email protected]

Broker:

AlbR Capital Limited      Tel: +44 (0) 207 469 0930

Important Legal Information

The information contained in this Announcement is for background purposes only and does not purport to be full or complete, nor does this Announcement constitute or form part of any invitation or inducement to engage in investment activity. No reliance may be placed by any person for any purpose on the information contained in this Announcement or its accuracy, fairness or completeness. The contents of this Announcement are not to be construed as legal, financial or tax advice.

This Announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.

This Announcement may include forward-looking statements, which are based on current expectations and projections about future events, including about the Group's operations, strategy, financial performance, development milestones, and the future prospects of its business divisions, including capMedia Inc, capMedical Inc, capMedia (UK) Ltd and capMedical (UK) Ltd. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and any other words and terms of similar meaning or the negative thereof.

Forward-looking statements are based on current expectations and are subject to various risks and uncertainties that could cause actual outcomes to differ materially. These risks include, but are not limited to: successful execution of definitive agreements; regulatory approvals; development timelines; market acceptance; technological shifts; and broader economic conditions. No representation or warranty is made or will be made that any forward-looking statement will come to pass, and no assurance can be given that any forward-looking statement will prove accurate. Except as required by law, capAI undertakes no obligation to revise or update any forward-looking statement. The forward-looking statements in this Announcement speak only as at the date of this Announcement.